Coronavirus disease 2019 (COVID‐19) in two pediatric patients with kidney disease on chronic immunosuppression: A case series

Coronavirus disease 2019 (COVID‐19) is a highly infectious disease caused by the severe acute respiratory syndrome coronavirus 2 virus (SARS‐CoV‐2). While children appear to experience less severe disease than adults, those with underlying conditions such as kidney disease may be more susceptible to infection. Limited data are present for children with kidney disease, and there are limited prior reports of pediatric hemodialysis patients with COVID‐19. This report describes the mild clinical disease course of COVID‐19 in two pediatric patients with chronic kidney disease, one on hemodialysis and both on chronic immunosuppression. We review treatment in these patients, as well as our measures to reduce transmission among our hemodialysis patients and staff.

[1]  G. Ghiggeri,et al.  COVID-19 in Children with Nephrotic Syndrome on Anti-CD20 Chronic Immunosuppression. , 2020, Clinical journal of the American Society of Nephrology : CJASN.

[2]  A. Carroll,et al.  Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit. , 2020, JAMA.

[3]  M. Marlais,et al.  The severity of COVID-19 in children on immunosuppressive medication , 2020, The Lancet Child & Adolescent Health.

[4]  H. Omran,et al.  First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  G. Ding,et al.  How we mitigated and contained the COVID-19 outbreak in a hemodialysis center: Lessons and experience , 2020, Infection Control & Hospital Epidemiology.

[6]  T. Skoff,et al.  Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[7]  Jun Liu,et al.  Factors associated with prolonged viral RNA shedding in patients with COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  T. Rea,et al.  Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington , 2020, The New England journal of medicine.

[9]  A. Kliger,et al.  Mitigating Risk of COVID-19 in Dialysis Facilities. , 2020, Clinical journal of the American Society of Nephrology : CJASN.

[10]  G. Wong,et al.  SARS-CoV-2 Infection in Children , 2020, The New England journal of medicine.

[11]  Edward Livingston,et al.  Coronavirus Disease 2019 (COVID-19) in Italy. , 2020, JAMA.

[12]  N. Curtis,et al.  Coronavirus Infections in Children Including COVID-19 , 2020, The Pediatric infectious disease journal.

[13]  Lei Liu,et al.  2019 novel coronavirus disease in hemodialysis (HD) patients: Report from one HD center in Wuhan, China , 2020, medRxiv.

[14]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[15]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[16]  Lorien S. Dalrymple,et al.  Epidemiology of acute infections among patients with chronic kidney disease. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[17]  P. Askenase,et al.  Immune defects in chronic renal impairment: evidence for defective regulation of lymphocyte response by macrophages from patients with chronic renal impairment on haemodialysis. , 1986, Clinical and experimental immunology.